FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutical formulations and methods for preparing them of lipids for ophthalmological application containing a phospholipid ingredient containing natural zwitterion phospholipids, and an oil ingredient containing natural oil-in-water emulsions. The oil ingredient and phospholipid ingredient are preferentially related as 3:1; the phospholipid ingredient is found in the amount of 0.1%-5%, and the oil ingredient is found in the amount of 0.3%-15%.
EFFECT: group of inventions provides ocular drug delivery applicable for treating dry eye syndrome; it has an ability to recover the lipid lachrymal film layer, inhibits the inflammatory element observed.
37 cl, 19 tbl, 4 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
| LIPID-BASED OPHTHALMIC EMULSION | 2019 |
|
RU2793333C2 |
| OPHTHALMIC COMPOSITION | 2012 |
|
RU2625301C2 |
| OPHTHALMOLOGICAL COMPOSITION, BASED ON POLYUNSATURATED FATTY ACIDS OMEGA-3 AND OMEGA-6 | 2010 |
|
RU2545675C2 |
| PHARMACEUTICAL EMULSION CONTAINING BIOLOGICALLY ACTIVE STEROIDS AND METHOD OF EMULSION PREPARING | 1994 |
|
RU2141313C1 |
| METHOD AND COMPOSITION TO OBTAIN MEMBRANE UPON OCULAR SURFACE | 1991 |
|
RU2092138C1 |
| EMULSION OF TYPE "OIL-IN-WATER", CARRIER ON ITS BASE AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2131266C1 |
| ARTIFICIAL TEARS AND THERAPEUTIC APPLICATION | 2010 |
|
RU2589837C2 |
| EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
| NEW USE OF NICOTINAMIDE MONONUCLETIDE (NMN) AND NICOTINAMIDE RIBOSIDE (NR) | 2020 |
|
RU2822512C2 |
